We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Bristol Myers Squibb Co | NYSE:BMY | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 44.21 | 0 | 01:00:00 |
From May 2019 to May 2024
By Colin Kellaher
Bristol-Myers Squibb Co. (BMY) Friday said John Elicker, executive vice president of corporate affairs and investor relations, will retire March 31.
The New York biopharmaceutical company said Kathryn Metcalfe, currently chief communications officer at CVS Health Corp. (CVS), will join as executive vice president of corporate affairs, effective Jan. 6.
Bristol-Myers said Ms. Metcalfe, who became communications chief at CVS as part of its acquisition of Aetna, will join its leadership team and report to Chairman and Chief Executive Giovanni Caforio.
A CVS spokesman said the Woonsocket, R.I., healthcare-services company has begun a search for Ms. Metcalfe's successor, adding that it will include internal and external candidates.
Mr. Elicker joined Bristol-Myers Squibb in 2000 as senior director of investor relations. The company said it named Tim Power vice president and head of investor relations, effective upon Mr. Elicker's retirement March 31.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
December 13, 2019 10:54 ET (15:54 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Bristol Myers Squibb Chart |
1 Month Bristol Myers Squibb Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
